PDGFRB and neoplasm: Moreover, the excess amount of PDGFRβ ligand can reduce [77Br]2 uptake in PDGFRβ-positive tumor cells (Fig. 6) and in the in vivo blocking experiments using tumor-bearing mice (Fig. 7).